Cell factories for insulin production

The rapid increase in the number of diabetic patients globally and exploration of alternate insulin delivery methods such as inhalation or oral route that rely on higher doses, is bound to escalate the demand for recombinant insulin in near future. Current manufacturing technologies would be unable...

Descripción completa

Detalles Bibliográficos
Autores principales: Baeshen, Nabih A, Baeshen, Mohammed N, Sheikh, Abdullah, Bora, Roop S, Ahmed, Mohamed Morsi M, Ramadan, Hassan A I, Saini, Kulvinder Singh, Redwan, Elrashdy M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203937/
https://www.ncbi.nlm.nih.gov/pubmed/25270715
http://dx.doi.org/10.1186/s12934-014-0141-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203937/
https://www.ncbi.nlm.nih.gov/pubmed/25270715
http://dx.doi.org/10.1186/s12934-014-0141-0

Ejemplares similares